Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes. - Wikidata - awgldk - TriplyDB

Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.

Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.

http://www.wikidata.org/entity/Q33163102

about

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular Tachycardia Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.Calcium signaling in human stem cell-derived cardiomyocytes: Evidence from normal subjects and CPVT afflicted patients Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.

P2860

Q26750618-C030823C-7A72-4EAB-A3B7-781DEFCBFE13 Q26781319-52CBBD76-AC1E-4961-B63A-A6A6571D7352 Q28067569-09116DB6-B307-449F-A843-A8295009CB98 Q33165988-5C6BCEB7-6BC8-4C5B-A92C-0C9817C36091 Q38454536-9FD04E0A-CB8B-4D97-8058-C2648A95C0AC Q38685507-0380FAF9-1CBA-4847-ABE6-1A3D89E3DCF4 Q39050993-47BA9790-7795-4CAC-9CF0-C9FFDE65A222

P2860

Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.

http://www.wikidata.org/entity/Q33163102

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Modeling Catecholaminergic Pol ...... m Cell-derived Cardiomyocytes.

@ast

Modeling Catecholaminergic Pol ...... m Cell-derived Cardiomyocytes.

@en

type

label

Modeling Catecholaminergic Pol ...... m Cell-derived Cardiomyocytes.

@ast

Modeling Catecholaminergic Pol ...... m Cell-derived Cardiomyocytes.

@en

prefLabel

Modeling Catecholaminergic Pol ...... m Cell-derived Cardiomyocytes.

@ast

Modeling Catecholaminergic Pol ...... m Cell-derived Cardiomyocytes.

@en

P1433

Q33163102-2E903EBC-6933-4F38-996A-08E1F259864E

P1476

Q33163102-A949704A-EB4F-4069-878B-0EFBA4073720

P2093

Q33163102-6217C45C-320C-4C47-9A2B-B8A12503F929

Q33163102-7A13283F-DFCA-49D3-BB89-5365156DC1F3

Q33163102-87C02F54-B297-43DC-B044-4A88103E32F9

Q33163102-D4FE9CA8-5816-4BD5-B46C-FC9D98F0BF98

P2860

Q33163102-0D8089F4-48FC-4205-B280-3827B154CF3A

Q33163102-0E5EAF3E-BD2C-4274-AA6D-02B8C1C2E7A5

Q33163102-0F683CE7-9E41-4139-8FA9-40EC23DD7FE4

Q33163102-156268FE-E57C-47A9-9291-0A5BCB10E686

Q33163102-17280C6C-B096-4129-B266-5C8EDBC373CA

Q33163102-193FE3AA-A360-4A1D-83B1-B1496360F92D

Q33163102-19613EB1-36C8-4306-90C2-AF621324D3FA

Q33163102-19E31B9E-48D4-49A1-AEB7-9859B6A44881

Q33163102-2A780C45-8E31-4CCE-B327-507C656A0E4A

Q33163102-30F1AD69-A4F7-4E1C-90B7-61161969F5DB

P304

Q33163102-52DC66ED-E70D-40A8-8173-908A102B3540

P31

Q33163102-F26D62A6-BEF2-42E3-8FE0-FA4EB368CDE8

P356

Q33163102-5AE1D37F-C198-4A4C-B84D-3F9969182B05

P407

Q33163102-54EC4E88-B904-4C63-BF2E-1B9018B053A3

P433

Q33163102-EF1C4717-830D-4142-8597-BBE3D40FD145

P478

Q33163102-153E840F-9A6C-4B0A-8E34-9CAD89D6EBC9

P577

Q33163102-6C711EFA-47C9-4576-ABD3-AEDBFD1817BB

P5875

Q33163102-A3BA82EC-B1EA-4A0E-9BA7-1DED9BFA4CC6

P698

Q33163102-239BD4E4-81BA-43B7-917F-D7F0CF03FE42

P921

Q33163102-223E05A4-B73C-4EF0-8E5C-020213575601

Q33163102-7E16CD9C-2462-432D-AD13-7B12BE06CC45

P932

Q33163102-24C51AF4-A91E-4689-8721-66003FDA91DA

P356

P1433

Rambam Maimonides Medical Journal

P1476

Modeling Catecholaminergic Pol ...... m Cell-derived Cardiomyocytes.

@en

P2093

Atara Novak

http://www.w3.org/2001/XMLSchema#string

Avraham Lorber

http://www.w3.org/2001/XMLSchema#string

Joseph Itskovitz-Eldor

http://www.w3.org/2001/XMLSchema#string

Ofer Binah

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia

Calsequestrin 2 and arrhythmias

Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

Cardiac excitation-contraction coupling

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia

P304

e0015

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5041/RMMJ.10086

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

254285265

http://www.w3.org/2001/XMLSchema#string

P698

23908839

http://www.w3.org/2001/XMLSchema#string

P921

catecholaminergic polymorphic ventricular tachycardia

P932

3678817

http://www.w3.org/2001/XMLSchema#string